Topics: Immunology, Infectious Disease evolution, Vertebrate Immunity, nonspecific immunity, specific immunity, antigens, epitopes, antibodies, Antigenic Variation, Specificity, Cross-Reactivity, Antigens, Antibody Epitopes, Antibody Paratopes, Antibody Affinity Maturation, Natural Antibodies, mutation, hypermutation, Intragenomic Recombination, Immunodominance, Antibody Immunodominance, CTL Immunodominance, Immune Regulation, Immunological Memory, Immunodominance of Memory, Antigenic Linkage Disequilibrium, Antigenicity, Phylogeny, Experimental Evolution, Antibody Escape Mutants, cell binding, cell tropism, Experimental Evolution, influenza, Antibody Escape Mutants

Topics: Antigens antibodies, Immune response, innate immunity, genetic immunity, acquired immunity, Naturally Acquired Active Immunity, Naturally Acquired Passive Immunity, Artificially Acquired Immunity, Artificially Acquired Passive Immunity, serum, antiserum, serology, gamma globulins, serum sickness, Humoral Immunity, Antibody-Mediated immunity, epitopes, Antibody Structure, Immunoglobulin Classes, clonal selection, Apoptosis, antibody binding, Immunological Memory, T Cells, cell mediated immunity, Cytotoxic T Cells, Destroy target cells, Cytotoxic T Cells Lyse Infected Cells, Delayed Hypersensitivity T Cells, T Suppressor Cells, Activated Macrophages, Stimulated phagocytes, Natural Killer Cells, Antibody Production, T-Dependent Antigens, Antibody Dependent Cell Mediated Cytotoxicity

Topics: Monoclonal antibodies, PROTEIN TYROSINE KINASE INHIBITORS, Imatinib, Dasatinib, Nilotinib, IMATINIB MESYLATE, DASATINIB, SPRYCEL, NILOTINIB, TASIGNA, Gefitinib, Iressa, Erlotinib, TARCEVA, Lapatinib, Tyverb, Trastuzumab, HERCEPTIN, Cetuximab, ERBITUX

Topics: Monoclonal gamma globulin disorder, myeloma, multiple myeloma, leukaemia, plasma cell leukaemia, Waldenstrom's macroglobulinaemia, heavy chain disease

Topics: Antibody-mediated immunity, humoral immunity, antibodies, Immunoglobulin Structure, Human Immunoglobulin Classes, Monoclonal Antibody, immunological memory, antibody binding

Topics: Molecular Biotechnology, Biophysical Analysis, Biochemical Analysis, Production of Recombinant Proteins, Purification of Recombinant Proteins, Biotech Products, Biopharmaceutical Considerations, Pharmacokinetics, Pharmacodynamics, Immunogenicity of Therapeutic Proteins, Therapeutic Proteins, Monoclonal Antibodies, Genomics, Biosimilars, Insulin, Follicle-Stimulating Hormone, Human Growth Hormone, Recombinant Coagulation Factors, Thrombolytic Agents, Recombinant Human Deoxyribonuclease, Monoclonal Antibodies in Cancer, Hematopoietic Growth Factors, Antibody-Based Biotherapeutics, Interferons, Interleukins, Vaccines, Oligonucleotides, Gene Therapy, Stem Cell Technology

Topics: Trastuzumab, herceptin, cetuximab, erbitux, panitumumab, vectibix, proteasome inhibitors, bortezmib

Topics: Clinical Immunology, immune system, innate immune responses, adaptive immune responses, Phagocytosis, natural killer cells, Eosinophils, antigen presenting cell, antigen presenting molecules, Monoclonal Antibodies, clinical trials, Xenotransplantation, cytokines, Cells of Adaptive Immunity, B-lymphocyte Antigen-specific Receptor, B-cell Differentiation, T-lymphocyte Antigen-specific Receptor, bone marrow, Antigen Dependent B-cell Differentiation, T Lymphocytes, inflammation, Vasodilatation, Increased Vascular Permeability, Edema, host defense, immunization, passive immunization, vaccines, vaccine technology, Hypersensitivity Reactions, Immediate Hypersensitivity Reactions, Antibody-mediated Hypersensitivity Reactions, Immune-complex Mediated Hypersensitivity, Cell-mediated Hypersensitivity, autoimmunity, Immunotherapy, Autoimmune Disorders, autoreactive antibodies, Immunodeficiency Disorders, Tumor Immunology, tumor antigens, Tumor Immunosurveillance, transplantation, Graft Rejection

Topics: Exogenous antigens, Injurious immune reactions, IMMEDIATE Hypersensitivity, TYPE 1 HYPERSENSITIVITY, Systemic anaphylaxis, Local immediate hypersensitivity, ANTIBODY-MEDIATED hypersentivity, TYPE 2 HYPERSENTIVITY, Opsonization, Membrane Attack Complex, Fc Receptor-Mediated Inflammation, Antibody-Mediated Cellular Dysfunction, IMMUNE COMPLEX-MEDIATED Hypersensitivity, TYPE 3 HYPERSENSITIVITY, Exogenous antigen, Endogenous antigen, SYSTEMIC IMMUNE COMPLEX DISEASE, Acute Serum Sickness, Acute Inflammatory Reaction, Fibrinoid Necrosis, LOCAL IMMUNE COMPLEX DISEASE, ARTHUS REACTION, Cell-mediated hypersensitivity, DELAYED TYPE HYPERSENTIVITY, GRANULOMATOUS inflammation, GRANULOMA, TYPE 4 HYPERSENSITIVITY

Topics: NORMAL IMMUNE RESPONSE, Innate Immunity, Adaptive Immunity, Lymphocytes, Macrophages, T lymphocytes, dendritic cells, Natural Killer Cells, Immunologic Memory, HYPERSENSITIVITY REACTIONS, IMMEDIATE HYPERSENSITIVITY, antibody-dependent cellular cytotoxicity, Antibody mediated cellular dysfunction, IMMUNE COMPLEX MEDIATED HYPERSENSITIVITY, T-Cell Mediated Delayed Type Hypersensitivity, T-CELL MEDIATED HYPERSENSITIVITY, T-Cell Mediated Cytotoxicity